首页> 外文期刊>Nuclear science and engineering >Analysis of the Effects of Radiolytic-Gas Bubbles on the Operation of Solution Reactors for the Production of Medical Isotopes
【24h】

Analysis of the Effects of Radiolytic-Gas Bubbles on the Operation of Solution Reactors for the Production of Medical Isotopes

机译:放射性气体气泡对医用同位素生产用溶液反应器运行的影响分析

获取原文
获取原文并翻译 | 示例
           

摘要

One of the primary methods to produce medical isotopes, such as ~(99)Mo, is by irradiation of uranium targets in heterogeneous reactors. Solution reactors present a potential alternative to produce medical isotopes. The Medical Isotope Production Reactor (M1PR) concept has been proposed to produce medical isotopes with lower uranium consumption and waste than those in heterogeneous reactors. Commercial production of medical isotopes in solution reactors requires steady-state operation at ~200 kW. At this power regime, fuel-solution temperature increase and radiolytic-gas bubble formation introduce a negative reactivity feedback that has to be mitigated. A model based on the point reactor kinetic equations has been developed to investigate these reactivity effects. This model has been validated against experimental results from the Los Alamos National Laboratory uranyl fluoride Solution High-Energy Burst Assembly (SHEBA) and shows the feasibility of solution reactors for the commercial production of medical isotopes.
机译:产生医学同位素(例如〜(99)Mo)的主要方法之一是在异质反应堆中辐照铀靶。溶液反应器是生产医学同位素的潜在替代品。有人提出了医用同位素生产反应堆(M1PR)的概念来生产比异质反应堆中的铀消耗和废物少的医用同位素。溶液反应器中医学同位素的商业化生产需要在〜200 kW下稳定运行。在这种功率状态下,燃料溶液温度的升高和放射性气泡的形成会带来负面的反应性反馈,必须予以缓解。已经开发了基于点反应器动力学方程的模型来研究这些反应性影响。该模型已针对美国洛斯阿拉莫斯国家实验室的铀酰氟溶液高能爆破组件(SHEBA)的实验结果进行了验证,并显示了溶液反应器在医学同位素商业化生产中的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号